Friedreich Ataxia Treatments
Find Friedreich Ataxia Treatments
Skyclarys
What is Skyclarys (Omaveloxolone)?
Approved To Treat
Related Clinical Trials
Summary: This is a clinical trial examining to impact of aerobic training plus omaveloxolone in FRDA. Thirty individuals with FRDA will be recruited; 20 individuals will be on omaveloxolone treatment whereas the other ten individuals will not. Individuals will undergo baseline assessment including cardiopulmonary exercise testing (CPET), mFARS, gait speed, Timed Up and Go (TUG), Fatigue Severity Scale (FSS...
Summary: In this study, researchers will learn more about the safety of BIIB141, also known as omaveloxolone or SKYCLARYS. This is a drug available for doctors to prescribe for people with Friedrich's Ataxia, also known as FA. This is known as an observational study, which collects health information about study participants without changing their medical care. Participants for this study will have taken B...
Summary: Friedreich's ataxia (FA) is a rare, inherited neurodegenerative disease that typically begins in children and young people. It primarily affects the spinal cord, peripheral nerves and cerebellum of the brain. Clinical manifestations include progressive gait and limb ataxia, auditory and optic neuropathy, cardiomyopathy, scoliosis, dysarthria, and dysphagia. In advanced stages, individuals may beco...
Related Latest Advances
Brand Information
- Elevation of aminotransferases
- Elevation of BNP
- Lipid abnormalities
